Document Detail


HIV transmission and primary drug resistance.
MedLine Citation:
PMID:  16736948     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Transmission of HIV viruses harboring resistance mutations is already a major concern in developed countries, with the potential to impact on therapeutic strategies. Several factors influence the transmission of such viruses, including viral replication fitness and transmission fitness, although behavioral characteristics must also be considered. Rates of transmission of specific mutations are related to therapeutic strategies. Reports of the transmission of multidrug-resistant viruses should alarm the medical community. An additional concern is the use of monotherapy with nevirapine for the prevention of mother-to-child transmission of HIV in developing countries as this practice selects for resistance to nonnucleoside reverse transcription inhibitors and could limit future therapeutic options of both the mothers and infected children. HIV treatment guidelines have evolved, shifting from more aggressive to more conservative approaches. This change of strategy has had a direct impact on the prevalence of drug-resistant virus in the population and the transmission of resistant viral species.
Authors:
Dan Turner; Mark A Wainberg
Related Documents :
16549978 - Molecular analysis of hiv strains from a cluster of worker infections in the adult film...
16420058 - Structure-activity relationship studies of novel benzophenones leading to the discovery...
9468368 - A survey of drug-resistant mycobacterium tuberculosis and its relationship to hiv infec...
12167268 - Extent and importance of cross-resistance to efavirenz after nevirapine failure.
8979308 - Thromboxane a2 analogue contracts predominantly the hepatic veins in isolated canine li...
17880448 - Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  AIDS reviews     Volume:  8     ISSN:  1139-6121     ISO Abbreviation:  AIDS Rev     Publication Date:    2006 Jan-Mar
Date Detail:
Created Date:  2006-06-01     Completed Date:  2006-06-15     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  101134876     Medline TA:  AIDS Rev     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  17-23     Citation Subset:  IM    
Affiliation:
AIDS Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Retroviral Agents / therapeutic use*
Child
Developing Countries
Drug Resistance, Multiple, Viral / genetics*
Drug Therapy, Combination
Female
HIV Infections / congenital,  transmission*
HIV-1 / drug effects*
Humans
Infectious Disease Transmission, Vertical / prevention & control
Pregnancy
Pregnancy Complications, Infectious
Reverse Transcriptase Inhibitors / therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Retroviral Agents; 0/Reverse Transcriptase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New findings on transcription regulation across different HIV-1 subtypes.
Next Document:  Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pre...